Trilogy Capital
QLTY icon

Trilogy Capital’s GMO US Quality ETF QLTY Stock Holding History

Trilogy Capital’s Portfolio QLTY Stock Details QLTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$319K Buy
+7,447
New +$316K 0.01% 333

Other funds holding QLTY

AIA Group
AIA Group Hong Kong $8.11B AUM 23.7% 1-Year Est. Return
Merit Financial Group
Merit Financial Group Alpharetta, Georgia $17.9B AUM 18.85% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Legacy Advisors
Legacy Advisors Plymouth Meeting, Pennsylvania $1.05B AUM 17.6% 1-Year Est. Return
Crestwood Advisors Group
Crestwood Advisors Group Boston, Massachusetts $6.76B AUM 24% 1-Year Est. Return
Perigon Wealth Management
Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Prodigy Asset Management
Prodigy Asset Management Omaha, Nebraska $335M AUM 5.94% 1-Year Est. Return

Trilogy Capital's QLTY Position: Q3 2026 in Review

Trilogy Capital opened a new position in GMO US Quality ETF (QLTY) in Q3 2026: 7,447 shares worth $319K. The stake represents 0.01% of the portfolio and ranks #333 among its holdings.

93 funds tracked by Wall St. Rank hold QLTY as of Q3 2026.

  • Trilogy Capital held 7,447 shares of GMO US Quality ETF worth $319K as of Q3 2026.
  • GMO US Quality ETF was a new Trilogy Capital position in Q3 2026.
  • GMO US Quality ETF made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #333 holding.
  • 93 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.